The way cancer is treated is about to change. Close monitoring during treatment will become possible, telling us within days with much greater precision if a treatment is working or not. Long-term monitoring of patients in remission will also be revolutionized by making fewer biopsies necessary and detecting relapses much earlier. All these promises come …
SQZ’s successful IPO validates the vision laid out by Armon Sharei, PhD in this interview recorded two years ago. In accessible language, this genius founder explains the approach that has big strategic players excited. SQZ is the model I have in mind when I invest in biotech companies. Find out why. Armon Sharei wants to …
Coming from a family of lawyers in Italy, Laura Indolfi was an unlikely candidate to found a tech startup. Yet, her love of engineering and fascination with materials took her to the storied labs at MIT led by Elazer Edelman and Bob Langer. Her startup, PanTher Therapeutics is using off-the-shelf cancer drugs and biomaterials to …
Engineer and consultant Susan Conover’s struggle with skin cancer inspires her to apply AI to help us understand what’s going on with our skin. This determined founder has made considerable headway in building the most valuable asset an AI startup can have: a strong, proprietary data set. A fun interview with a dynamic founder. HIGHLIGHTS …
Brilliant Spanish postdoc, Carlos Castro-González, goes to MIT’s “Magic Wand” lab, and joins a superb international team to address an important medical problem. Leuko, their startup, now has a device and software that can tell when cancer patients are becoming immuno-compromised. Leuko’s product has the potential of saving 4,000 lives and $1.5 billion every year …
Carlos Castro-González, “To Save 4000 Lives a Year” Read More »
Founder Gillian Isabelle, Ph.D. returns to give us an update on how her startup Enlivity is navigating the COVID crisis. Listen to my full interview with Gillian Isabelle here.
Jeff Behren’s doctoral dissertation suggests that life science startups are not funded the way we all think they are. Listen to our discussion of his work and learn why he believes we have to revise what is taught to founders in entrepreneurship classes about how to raise money. HIGHLIGHTS Sal Daher Welcomes Jeff Behrens Back …
Jeff Behrens, “Why You’re Wrong About Biotech Funding” Read More »
Microbiologist Alex Sakatos felt strongly that valuable science was not making it from the lab to the clinic. This led her to start Ancilia which is finding ways to protect good bacteria in our gut from attack by viruses. A great chat about an exciting field in biotech. HIGHLIGHTS FROM OUR INTERVIEW Sal Daher Introduces …
Alex Sakatos, “Ancilia: Defending Healthy Gut Bacteria” Read More »
Purdue wants to be Startup U. They are already the #3 university in the US for producing startups, right behind MIT and Columbia. One of my favorite companies, Savran Technologies, came out of Purdue. I spoke with Wade Lange of Purdue Foundry which is responsible for promoting startups at Purdue. Several interesting Purdue startups were …
Kristen Overly works as management consultant and is a leader at MIT Life Science Angels. Kristen and I discussed various aspects of the funding of life science startups. She, like me, is intrigued by the opportunities in what Jeff Behrens called the scrappy biotechs in his doctoral thesis. HIGHLIGHTS INCLUDE Sal Daher Introduces Kristen Overly …
